On March 29, 2019, Ravenquest Biomed Inc. (CNSX:RQB) closed the transaction. The company amended the terms of the transaction. The company has issued 166,000 units for proceeds of CAD 99,600 in its second tranche, bringing the total gross proceeds raised in the transaction to CAD 2,213,899.20. The company paid cash fees of CAD 52,013.99 and issued 86,690 warrants to eligible finders. All the securities issued in the transaction are subject to a hold period of four months and one day from the date of closing. The company raised CAD 420,000.8232 in funding in the transaction from two investors pursuant to Regulation D.